Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 12.1B | 11.1B | 9.9B | 12.8B |
Cost of revenue | 8.6B | 8.0B | 7.0B | 9.2B |
Gross profit | 3.5B | 3.1B | 2.8B | 3.6B |
Operating expense | ||||
Research & development | 730.4M | 911.3M | 551.8M | 640.2M |
Selling general and admin | 1.5B | -1.8B | 2.9B | 158.4M |
Other operating expenses | 70.9M | 97.0M | 77.8M | 77.6M |
Operating income | 1.2B | 672.7M | 897.9M | 1.4B |
Non operating interest income | ||||
Income | 107.3M | 128.9M | 203.6M | 145.1M |
Expense | 140.4M | 166.2M | 128.2M | 169.9M |
Other income expense | — | — | — | — |
Pretax income | 1.7B | 491.4M | 1.0B | 1.7B |
Tax provision | 197.1M | -25.0M | 77.2M | 166.0M |
Net income | 1.5B | 516.5M | 950.3M | 1.5B |
Basic EPS | 0.2 | — | — | — |
Diluted EPS | 0.2 | — | — | — |
Basic average shares | 70.9B | — | — | — |
Diluted average shares | 70.9B | — | — | — |
EBITDA | 1.5B | 688.7M | 1.3B | 1.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | -105.8M | -135.1M | -99.3M | -149.4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |